🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Removal

According to TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company stated it was committed to maintaining the platform safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.

Within moments of entering one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, messages display black plastic packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly serious medical dangers”.